How has the lopinavir price changed over time?
The provided information does not include any data on lopinavir pricing history, so a trend line (for example, monthly or yearly changes) can’t be established from what’s available here.
What causes lopinavir prices to move (even if demand stays the same)?
Without specific pricing records in the provided material, the main drivers can only be described generally. Drug prices commonly change due to shifts in:
- Competition (e.g., generics entering the market)
- Patent or exclusivity status
- Manufacturer pricing decisions and contract pricing
- Health-system tendering and reimbursement rules
What price should you compare (brand vs generic, and which country)?
Price trends vary a lot by:
- Country and procurement model (retail vs hospital vs government tender)
- Formulation (e.g., tablets vs liquid formulations)
- Brand name vs generic equivalent
To track a real trend, you need at least the country, the exact product/strength/formulation, and the time window.
Can you share the data source so I can compute the trend?
If you paste or link the pricing table you’re using (or tell me the country and source—such as a national drug price database, tender dataset, or pharmacy website), I can:
- Extract the timeline points
- Compute percentage changes
- Identify periods where prices spiked or dropped
- Summarize the overall direction of the trend
Quick clarification questions
1) Which country’s lopinavir price are you interested in?
2) Is it lopinavir/ritonavir (Kaletra) or lopinavir alone?
3) What formulation (tablets or oral solution) and strength?
4) What date range (e.g., last 12 months, since 2018)?
If you answer those, I can produce a clear “price trend” narrative for the exact product you mean.